The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis
1 other identifier
interventional
40
1 country
1
Brief Summary
This interventional clinical trial aims to investigate the effects of internal and external focus-based exercise training combined with cognitive dual-task training in individuals diagnosed with multiple sclerosis. The primary objective is to determine whether these exercise approaches improve gait, balance, and cognitive functions. The main research questions are: Does dual-task training combined with internal focus-based exercises improve gait, balance, and cognitive performance? Does dual-task training combined with external focus-based exercises lead to greater improvements compared to internal focus strategies? Participants will be divided into two groups, and the researchers will compare the effects of internal focus-based and external focus-based dual-task exercise training on functional outcomes. Participants will: Perform structured exercise sessions under the supervision of a physiotherapist Engage in dual-task activities by combining motor exercises with simple cognitive tasks (e.g., backward counting, word generation) Participate in an 8-week training program, with sessions held twice a week lasting approximately 45-60 minutes Undergo assessments of gait, balance, and cognitive function before and after the intervention This study does not involve invasive procedures or biological sample collection. The findings are expected to contribute to the development of more effective dual-task rehabilitation strategies for individuals with multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Mar 2026
Typical duration for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2026
CompletedFirst Submitted
Initial submission to the registry
March 27, 2026
CompletedFirst Posted
Study publicly available on registry
April 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2028
April 2, 2026
March 1, 2026
1.3 years
March 27, 2026
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait Performance Under Dual-Task Conditions
Gait performance will be assessed using the Zebris FDM System (FDM 1.5). Parameters will include step length, stride length, step width, step time, stride time, cadence, gait speed, stance phase percentage, swing phase percentage, and double support phase percentage under dual-task conditions.
Baseline and after 8 weeks
Secondary Outcomes (2)
Cognitive Function (BICAMS)
Baseline and after 8 weeks
Balance Performance
Baseline and after 8 weeks
Study Arms (2)
Internal Focus Training
EXPERIMENTALParticipants receive dual-task exercise training with internal focus instructions.
External Focus Training
EXPERIMENTALParticipants receive dual-task exercise training with external focus instructions directed toward movement effects or external targets.
Interventions
Participants perform dual-task exercise training with instructions focusing on their own body movements during task execution. The program includes gait, balance, and cognitive tasks.
Participants receive dual-task exercise training with external focus instructions directed to movement effects or external targets. The program includes gait, balance, and cognitive tasks performed simultaneously.
Eligibility Criteria
You may qualify if:
- Diagnosis of Multiple Sclerosis according to the revised McDonald criteria
- Aged between 20 and 60 years
- Ability to understand and follow simple instructions
- Ability to stand and walk independently or with an assistive device
- Ability to speak and understand Turkish
- Score of ≥21 on the Montreal Cognitive Assessment (MoCA)
- Willingness to participate in the study
You may not qualify if:
- MS relapse within the last 30 days
- Presence of any other neurological disease besides Multiple Sclerosis
- Any musculoskeletal condition that may affect walking or balance
- History of uncontrolled cardiorespiratory conditions within the last 3 months (e.g., hypertension, arrhythmia, tachycardia, or acute cardiopulmonary events)
- Severe visual or hearing impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kütahya Sağlık Bilimleri Üniversitesi, Sağlıklı Yaşam Fizyoterapi ve Rehabilitasyon Merkezi
Kütahya, Merkez, 43000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors and data analysts will be blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Ph.D.
Study Record Dates
First Submitted
March 27, 2026
First Posted
April 2, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
August 30, 2028
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly available due to privacy and confidentiality concerns, as well as institutional and ethical restrictions. Data may be available from the corresponding investigator upon reasonable request and with appropriate ethical approval.